Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

Summary

The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

Timeline

Start

2020-04-13

Primary completion

2026-12-23

Completion

2027-12-30

Publications

• Park JB, Jang GY, Cho KY, Lee H, Kim KI. Factors affecting outcomes of intra-articular injection of autologous, culture-expanded, adipose-derived mesenchymal stem cells in knee osteoarthritis. Stem Cells Transl Med. 2026 May 18;15(6):szag027. doi: 10.1093/stcltm/szag027.

Drugs

Indications